<DOC>
	<DOCNO>NCT02337283</DOCNO>
	<brief_summary>The aim study investigate safety , tolerability , pharmacokinetics multiple rise dos BI 425809 tablet give orally daily 12 day young elderly healthy male female volunteer compare single dose pharmacokinetics BI 425809 give morning evening .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Multiple Rising Doses BI 425809 Tablets 12 Days Young Elderly Healthy Male Female Volunteers Comparison Pharmacokinetics Single Oral Dose BI 425809 ( Morning Versus Evening )</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Healthy male female subject accord investigatorÂ´s assessment , base complete medical history include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test age 18 50 year ( incl . ) young healthy volunteer age 65 80 year ( incl . ) elderly healthy volunteer Body mass index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) Signed date write informed consent prior admission study accordance good clinical practice ( GCP ) local legislation Female subject meet follow criterion : 1 . Surgically sterilise 2 . Postmenopausal , define least 1 year spontaneous amenorrhea ( questionable case blood sample simultaneous level follicle stimulate hormone ( FSH ) 40 U/L estradiol 30 ng/L confirmatory ) Exclusion criterion : Any find medical examination ( include BP , PR ECG ) deviate normal judge clinically relevant investigator Repeated measurement systolic blood pressure outside range 90 140 mmHg , diastolic blood pressure outside range 50 90 mmHg young subject , systolic blood pressure great 150 mmHg , diastolic blood pressure great 95 mmHg elderly subject , pulse rate outside range 50 90 bpm Any laboratory value outside reference range investigator considers clinical relevance Any evidence concomitant disease judge clinically relevant investigator Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract could interfere kinetics trial medication Diseases central nervous system ( include limit kind seizure stroke ) , relevant neurological psychiatric disorder History relevant orthostatic hypotension , faint spell , blackout Chronic relevant acute infection Further exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>